Scientists at Southampton University haveย created new antibodiesย that supercharge the immune systemโs ability toย identifyย and kill cancer cells. This approach involved clustering immune receptors in the body so that stronger signals can be sent out to the specialized cells responsible for zeroing in and killing cancer cells.ย
By using thisย new approachย to enable antibodies to attach to double the two ligands that existing antibodies normally attach to, and by recruiting CD27ย receptors to keep the antibody clump held together, the bodyโs immune system gets primed to launch a stronger attack against cancer, boosting effectiveness rates. This work adds onto what other teamsย atย Calidi Biotherapeutics Inc. (NYSE American: CLDI)ย and others are doing toโฆ
About BioMedWire
BioMedWireย (โBMWโ) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 75+ brands within theย Dynamic Brand Portfolioย @ย IBNย that delivers:ย (1) access to a vast network of wire solutions viaย InvestorWireย to efficiently and effectively reach a myriad of target markets, demographics and diverse industries;ย (2) article andย editorial syndication to 5,000+ outlets;ย (3) enhancedย press release enhancementย to ensure maximum impact;ย (4)ย social media distributionย via IBN to millions of social media followers;ย and (5) a full array of tailoredย corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in todayโs market, BMW brings its clients unparalleled recognition and brand awareness.
BMW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from BioMedWire, โBiotechโ to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visitย https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published:ย https://www.BioMedWire.com/Disclaimer
BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is powered byย IBN
